Back
Evaxion Biotech AS Vs. Novo Nordisk AS Industry Stock Comparison
Sell
28
EVAX
Evaxion Biotech AS
Last Price:
3.05
Seasonality Move:
-23.19%
Sell
48
NVO
Novo Nordisk AS
Last Price:
134.90
Seasonality Move:
4.32%
Sell
28
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
- The current Evaxion Biotech AS [EVAX] share price is $3.15. The Score for EVAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- EVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $134.88. The Score for NVO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $3.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $134.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 51.16 | Buy |
Chaikin Money Flow: | -15401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.05 - 3.29) | Sell |
Bollinger Bands (100): | (2.79 - 3.65) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 51.27 | Buy |
Chaikin Money Flow: | 1563194 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.59 - 137.27) | Sell |
Bollinger Bands (100): | (129.38 - 140.78) | Sell |
EVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.12 | Buy |
20-day SMA: | 3.16 | Sell |
50-day SMA: | 3 | Buy |
200-day SMA: | 4.12 | Sell |
8-day EMA: | 3.14 | Buy |
20-day EMA: | 3.13 | Buy |
50-day EMA: | 3.1 | Buy |
200-day EMA: | 4.71 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.31 | Buy |
20-day SMA: | 134.74 | Buy |
50-day SMA: | 133.43 | Buy |
200-day SMA: | 125.88 | Buy |
8-day EMA: | 134.15 | Buy |
20-day EMA: | 134.19 | Buy |
50-day EMA: | 134.27 | Buy |
200-day EMA: | 124.86 | Buy |
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.83 per share, an increase next quarter of $0.14 per share, an increase this year of $7.50 per share, and a decrease next year of $0.04 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.92 per share.
Evaxion Biotech AS Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |